...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Financials
1
Aug 07, 2019 05:15PM

Last year it reported quarterly. It is not following suit this year.

https://www.zenithepigenetics.com/about/corporate-information

Koo

6
Aug 09, 2019 11:05AM
6
Aug 09, 2019 11:26AM
2
Aug 09, 2019 11:57AM
4
Aug 09, 2019 12:17PM
Share
New Message
Please login to post a reply